U.S. markets closed
  • S&P 500

    3,699.13
    +32.41 (+0.88%)
     
  • Dow 30

    30,217.77
    +248.25 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,891.42
    +42.71 (+2.31%)
     
  • Crude Oil

    46.02
    +0.38 (+0.83%)
     
  • Gold

    1,839.80
    -1.30 (-0.07%)
     
  • Silver

    24.28
    +0.15 (+0.61%)
     
  • EUR/USD

    1.2130
    -0.0019 (-0.16%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • GBP/USD

    1.3437
    -0.0016 (-0.12%)
     
  • USD/JPY

    104.1680
    +0.3080 (+0.30%)
     
  • BTC-USD

    18,967.07
    -290.52 (-1.51%)
     
  • CMC Crypto 200

    371.81
    -7.44 (-1.96%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Collegium to Present at Upcoming Investor Conferences

STOUGHTON, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will present at the following investor conferences in June:

  • The Jefferies Healthcare Conference on Tuesday, June 4th in New York City. Management will present at 2:30pm ET.

  • The William Blair Growth Stock Conference on Wednesday, June 5th in Chicago. Management will present at 9:20am CT.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
adasalla@collegiumpharma.com